Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis

被引：0
|
作者：
Kenan Aksu
Ayhan Donmez
Yesim Ertan
Gokhan Keser
Vedat Inal
Gonca Oder
Murat Tombuloglu
Yasemin Kabasakal
Eker Doganavsargil
机构：
[1] Ege University School of Medicine Hospital,Internal Medicine
[2] Ege University School of Medicine Hospital,Rheumatology Division
[3] Ege University School of Medicine Hospital,Internal Medicine
来源：
Rheumatology International | 2007年 / 28卷
关键词：
Hodgkin’s lymphoma; Etanercept; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
It has been well known that anti-TNF drugs might increase lymphoma risk in rheumatoid arthritis (RA), where the rate of lymphoma has already been increased. However, unlike RA, an increased rate of lymphoma has not been reported in ankylosing spondylitis (AS). Hereby, we present a case with AS developing Hodgkin’s lymphoma (HL) following 6 months of etanercept treatment. Pathological analysis revealed mixed cellular type of HL. Although we report a single case, it should be kept in mind that anti-TNF drugs might cause lymphoma development not only in RA, but also in AS.
引用
收藏
相关论文
共 50 条
  • [21] Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept
    Xiaohu Deng
    Jianglin Zhang
    Jie Zhang
    Feng Huang
    Rheumatology International, 2013, 33 : 1409 - 1413
  • [22] Thalidomide reduces recurrence of ankylosing spondylitis in patients following discontinuation of etanercept
    Deng, Xiaohu
    Zhang, Jianglin
    Zhang, Jie
    Huang, Feng
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (06) : 1409 - 1413
  • [23] Infertility improved by etanercept in ankylosing spondylitis
    Rezvani, Aylin
    Ozaras, Nihal
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 (06) : 276 - 277
  • [24] Etanercept in ankylosing spondylitis: profile report
    Drugs & Therapy Perspectives, 2004, 20 (10) : 5 - 6
  • [25] New onset of Crohn's disease in three patients with ankylosing spondylitis during treatment with etanercept
    Song, I.
    Haibel, H.
    Brandt, J.
    Braun, J.
    Sieper, J.
    Rudwaleit, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 543 - 543
  • [26] Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis
    Liu, Ya-Fei
    Dong, Hui
    Tu, Sheno-Hao
    Zheng, Cui-Hong
    Liu, Pei-Lin
    Hu, Yong-Hong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (05) : 1585 - 1592
  • [27] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [28] Low dose etanercept treatment for maintenance of clinical remission in ankylosing spondylitis
    Park, J. W.
    Yoon, Y. I.
    Lee, J. H.
    Park, J. K.
    Lee, E. B.
    Song, Y. W.
    Lee, E. Y.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 592 - 599
  • [29] Scurvy as the Presenting Illness of Whipple's Disease Exacerbated by Treatment with Etanercept in a Patient with Ankylosing Spondylitis
    Hmamouchi, Ihsane
    Costes, Valerie
    Combe, Bernard
    Morel, Jacques
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1078 - 1080
  • [30] Etanercept for Ankylosing Spondylitis With Coexisting Demyelinating Myelitis
    Ye, Cong
    Geng, Zhe
    Li, Shouxin
    Yu, Fei
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (05) : E629 - E631
12345